Abstract
Cell culture experiments often employ the use of culture media that contain fetal calf serum (FCS). The angiotensin peptides angiotensin II and angiotensin 1–7 have opposing effects with angiotensin converting enzyme 2 (ACE2) being the enzyme predominantly responsible for generating angiotensin 1–7 from angiotensin II. The effect of FCS on angiotensin peptides has not previously been described. We have shown that FCS has ACE2 enzyme activity capable of degrading angiotensin II and generating angiotensin 1–7. Researchers should be aware that FCS possesses ACE2 activity and that heat-treating FCS to 56 °C only partially inhibits this enzyme activity, whereas heat-treating to 70 °C completely abolishes ACE2 activity.
References
Bataller R, Gines P, Nicolas JM et al (2000) Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology 118:1149–1156. doi:10.1016/S0016-5085(00)70368-4
Bataller R, Gabele E, Schoonhoven R et al (2003a) Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver. Am J Physiol Gastrointest Liver Physiol 285:G642–G651
Bataller R, Sancho-Bru P, Gines P et al (2003b) Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II. Gastroenterology 125:117–125. doi:10.1016/S0016-5085(03)00695-4
Bataller R, Gabele E, Parsons CJ et al (2005) Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats. Hepatology 41:1046–1055. doi:10.1002/hep.20665
Benter IF, Ferrario CM, Morris M et al (1995) Antihypertensive actions of angiotensin-(1–7) in spontaneously hypertensive rats. Am J Physiol 269:H313–H319
Burchill L, Velkoska E, Dean RG et al (2008) Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression. Exp Physiol 93:622–630. doi:10.1113/expphysiol.2007.040386
Burrell LM, Johnston CI, Tikellis C et al (2004) ACE2, a new regulator of the renin–angiotensin system. Trends Endocrinol Metab 15:166–169. doi:10.1016/j.tem.2004.03.001
Ferrario CM, Trask AJ, Jessup JA (2005) Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1–7) in regulation of cardiovascular function. Am J Physiol Heart Circ Physiol 289:H2281–H2290. doi:10.1152/ajpheart.00618.2005
Ferreira AJ, Santos RA, Almeida AP (2001) Angiotensin-(1–7): cardioprotective effect in myocardial ischemia/reperfusion. Hypertension 38:665–668
Ferreira AJ, Santos RA, Almeida AP (2002) Angiotensin-(1–7) improves the post-ischemic function in isolated perfused rat hearts. Braz J Med Biol Res 35:1083–1090. doi:10.1590/S0100-879X2002000900009
Freeman EJ, Chisolm GM, Ferrario CM et al (1996) Angiotensin-(1–7) inhibits vascular smooth muscle cell growth. Hypertension 28:104–108
Greenwood FC, Hunter WM, Glover JS (1963) The preparation of I-131-labelled human growth hormone of high specific radioactivity. Biochem J 89:114–123
Grobe JL, Mecca AP, Mao H et al (2006) Chronic angiotensin-(1–7) prevents cardiac fibrosis in DOCA-salt model of hypertension. Am J Physiol Heart Circ Physiol 290:H2417–H2423. doi:10.1152/ajpheart.01170.2005
Herath CB, Warner FJ, Lubel JS et al (2007) Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1–7) levels in experimental biliary fibrosis. J Hepatol 47:387–395. doi:10.1016/j.jhep.2007.03.008
Iwata M, Cowling RT, Gurantz D et al (2005) Angiotensin-(1–7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects. Am J Physiol Heart Circ Physiol 289:H2356–H2363. doi:10.1152/ajpheart.00317.2005
Kucharewicz I, Chabielska E, Pawlak D et al (2000) The antithrombotic effect of angiotensin-(1–7) closely resembles that of losartan. J Renin Angiotensin Aldosterone Syst 1:268–272. doi:10.3317/jraas.2000.041
Kucharewicz I, Pawlak R, Matys T et al (2002) Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1–7). Hypertension 40:774–779. doi:10.1161/01.HYP.0000035396.27909.40
Lambert DW, Hooper NM, Turner AJ (2008) Angiotensin-converting enzyme 2 and new insights into the renin–angiotensin system. Biochem Pharmacol 75:781–786. doi:10.1016/j.bcp.2007.08.012
Lew RA, Warner FJ, Hanchapola I et al (2008) Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor. Exp Physiol 93:685–693. doi:10.1113/expphysiol.2007.040352
Santos RA, Castro CH, Gava E et al (2006) Impairment of in vitro and in vivo heart function in angiotensin-(1–7) receptor MAS knockout mice. Hypertension 47:996–1002. doi:10.1161/01.HYP.0000215289.51180.5c
Strawn WB, Ferrario CM, Tallant EA (1999) Angiotensin-(1–7) reduces smooth muscle growth after vascular injury. Hypertension 33:207–211
Tallant EA, Ferrario CM, Gallagher PE (2005) Angiotensin-(1–7) inhibits growth of cardiac myocytes through activation of the mas receptor. Am J Physiol Heart Circ Physiol 289:H1560–H1566. doi:10.1152/ajpheart.00941.2004
Tipnis SR, Hooper NM, Hyde R et al (2000) A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275:33238–33243. doi:10.1074/jbc.M002615200
Voronov S, Zueva N, Orlov V et al (2002) Temperature-induced selective death of the C-domain within angiotensin-converting enzyme molecule. FEBS Lett 522:77–82. doi:10.1016/S0014-5793(02)02888-0
Warner FJ, Lubel JS, McCaughan GW et al (2007) Liver fibrosis: a balance of ACEs? Clin Sci (Lond) 113:109–118. doi:10.1042/CS20070026
Wei H, Lu H, Li D et al (2001) The expression of AT1 receptor on hepatic stellate cells in rat fibrosis induced by CCl4. Chin Med J (Engl) 114:583–587
Yokohama S, Tokusashi Y, Nakamura K et al (2006) Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis. World J Gastroenterol 12:322–326
Zhang Y, Yang X, Wu P et al (2003) Expression of angiotensin II type 1 receptor in rat hepatic stellate cells and its effects on cell growth and collagen production. Horm Res 60:105–110. doi:10.1159/000072520
Acknowledgments
This work was supported by an Australia National Health and Medical Research Council (NHMRC) grant. Dr. John Lubel is a recipient of an NHMRC (Australia) scholarship.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Lubel, J.S., Herath, C.B., Velkoska, E. et al. Angiotensin converting enzyme 2 (ACE2) activity in fetal calf serum: implications for cell culture research. Cytotechnology 58, 119–126 (2008). https://doi.org/10.1007/s10616-009-9185-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10616-009-9185-0